Anixa Biosciences Competitors and Similar CompaniesClear all

Anixa Biosciences's competitors and similar companies include Navigere, Vara, Immunovia and Eon.

	Anixa Biosciences Anixa Biosciences (formerly known as ITUS Corporation) is a biotechnology company providing diagnostic and therapeutic solutions for the early detection of tumor-based cancers.	Navigere Navigere (formerly known as Spreemo Diagnostics) is a one-call company whose mission is to connect injured workers with diagnostics providers.	Vara Vara is a company that develops a breast cancer screening platform powered by AI for radiologists, allowing them to focus on finding cancer early.	Immunovia Immunovia engages in the development of a technology platform based on antibody microarray analysis.	Eon Eon (also known as Matrix Analytics) is a health-tech company developing a platform to identify and manage patients with incidental findings.
Founding Date	Founding Date 1982	Founding Date 2012	Founding Date 2018	Founding Date 2007	Founding Date 2014
Type	Type Public	Type Private	Type Private	Type Public	Type Private
Tags	Tags Healthcare Technology healthtech medical diagnostics oncology platform	Tags Technology data management medical diagnostics	Tags Healthcare Technology artificial intelligence healthtech machine learning medical diagnostics oncology platform	Tags Healthcare Technology biotech medical diagnostics oncology platform	Tags Technology healthtech medical diagnostics oncology platform
Locations	Locations San Jose, US HQ	Locations Dallas, US HQ	Locations Berlin, DE HQ	Locations Lund, SE HQ Lund, SE Marlborough, US	Locations Denver, US HQ
Employees	Employees 7	Employees N/A	Employees 4711% decrease	Employees 9	Employees 9771% increase
Valuation ($)	Valuation ($) 127.8 m	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 10.2 m	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) kr685k (FY, 2025)	Revenue (est.) $5.7m (Y, 2021)
Net income	Net income ($11m) (FY, 2025)	Net income N/A	Net income N/A	Net income (kr145.9m) (FY, 2025)	Net income N/A
Funding
Total funding raised	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 10.4m	Total funding raised $ 5.2m	Total funding raised N/A